For those interested:
* A P2 trial in an undisclosed indication will cost less than $10m if design is similar to others already completed.
* FDA meeting in September is face to face. Jon is there 4-6 Sept at a conference so i suspect meeting is around this time too otherwise he will have to go back.
* Once the FDA meeting is completed. NEU will wait for the formal minutes to come. After they are received shareholders will be updated on the path forward which will be in the first part of Q4.
For those interested:* A P2 trial in an undisclosed indication...
-
- There are more pages in this discussion • 15 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$15.27 |
Change
0.920(6.41%) |
Mkt cap ! $1.951B | |||
| Open | High | Low | Value | Volume |
| $14.35 | $15.27 | $14.35 | $8.720M | 579.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1000 | $15.25 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $15.27 | 3638 | 4 |
View Market Depth
| Last trade - 16.10pm 27/09/2024 (20 minute delay) ? |
| NEU (ASX) Chart |